Viral Hepatitis B&D Flashcards
def of hepatitis B
infection with hepatitis B virus (HBV)
may follow an acute or chronic course
what is chronic HBV defined as
viraemia and hepatic inflammation >6months
def of hepatitis D
defective virus
may only:
1 co-infect with HBV
2 superinfect carriers of HBV
what sort of virus is HBV
enveloped, partially DS DNA virus
what sort of virus is HDV
SS RNA virus coated with HBsAg
aetiology
HBV:
- transmission by sexual contact, blood, vertical (mother to baby)
- viral proteins are produced (HBcAg-core antigen, HBsAg-surface antigen, HBeAg)
antibody + cell-mediated immune responses to viral replication lead to liver inflammation + hepatocyte necrosis
what is HBeAG a marker of
increased infectivity
associations/risk factors
1 HBV
- IV drug use
- infants of HBeAg positive mothers
- sexual contact with HBV carriers
who is at risk of chronic HBV carriage
babies
epi
HBV common in southeast asia, africa, uncommon in UK
350m worldwide infected with HBV, 1-2million deaths annually
history
1 incubation period (time between infection exposure and symptoms) of 3-6months 2 prodromal symptoms -malaise -nausea, vomiting, diarrhoea -RUQ pain 3 (occasionally) serum-sickness-type illness -arthralgia -maculopapular rash 4 dark urine + pale stools
examination
1 acute -jaundice -pyrexia -tender hepatomegaly -cervical lymphadenopathy 2 chronic -may have no findings -may be signs of CLD
investigations
1 viral serology
2 PCR
3 bloods
-LFTs (very high AST + ALT, high bilirubin, high alkphos)
-clotting (prolonged PT in severe disease)
4 liver biopsy
what does HBsAg positive, IgM anti-HBcAg indicate
acute HBV
what does HBsAg positive, IgG anti-HBcAg indicate
chronic HBV
what does anti-HBsAg positive, igG anti-HBcAg indicate
HBV cleared or immunity
why is PCR used in investigating HBV?
detection of HBV DNA is the most sensitive measure of ongoing viral replication
management by prevention
1 instrument sterilisation (IV drug users)
2 safe sex
3 passive+active immunisation (against HBV)
why is immunisation only required against HBV
HBV immunisation protects against HDV too
as HDV co-infects with HBV or superinfects carriers of HBV
management of acute HBV hepatitis
1 symptomatic control (antipyretics, antiemetics, cholestryamine for pruritis)
2 notify communicable disease control
management of chronic HBV
1 antivirals (if indicated)
- interferon-alpha, or
- nucleos/tide analogues (adefovir, tenofovir)
what are the indications for antivirals
1 HBeAg-positive or negative with chronic hepatitis
2 cirrhosis with HBV DNA by PCR
what is inteferon alpha
a cytokine which enhances the bodies antiviral effects
complications
1 fulminant hepatic failure (1%)
2 chronic HBV infection
3 cirrhosis
what is fulminant hepatic failure
acute liver injury impairing functioning and causing hepatic encephalopathy in a patient without previous liver disease
prognosis
10% become chronic, and of these, 20-30% will develop cirrhosis
high serum transaminases and low HBV DNA indicate a good response to interferon